- Valneva builds on traveler's vaccine franchise with €45m Dukoral buy
- Hilleman CEO on why new cholera vaccine could be "high impact"
- US Capitol Capsule: Fauci: Ebola must be a 'shake the cage moment'
- WHO: Best scenario puts Ebola vaccine late Q1 2015
ANALYSIS Other Informa Analysis
COMMENT Other Informa Comment
- Interview: building on Spiriva – Boehringer Ingelheim's Allan Hillgrove
- Profile: The ABPI's reimbursement director on Pfizer, his TicTac salary, and paper mache